Laronib 100mg Larotrectinib Capsule In Pakistan
Laronib 100mg Larotrectinib Capsule In Pakistan
Laronib 100mg contains larotrectinib, a targeted kinase inhibitor used for the treatment of certain solid tumors that have an NTRK gene fusion without a known acquired resistance mutation. It may be prescribed for adults and pediatric patients when the tumor is metastatic, surgery would cause significant morbidity, and there are no satisfactory alternative treatments or the disease has progressed following treatment. Patient selection is based on appropriate molecular testing.
Key Benefits
- Targeted treatment for eligible NTRK gene fusion-positive solid tumors.
- May be used in adults and pediatric patients when clinically appropriate.
- Provides an oral targeted-therapy option for selected patients.
- Available as a 100mg capsule formulation.
- Treatment selection is based on the molecular characteristics of the tumor.
How to Use
Take Laronib 100mg exactly as prescribed by an oncologist. For adults and pediatric patients with a body surface area of at least 1 m², the labeled larotrectinib dosage is 100mg orally twice daily, with or without food. Pediatric dosing for patients with a body surface area below 1 m² is weight/body-surface-area based. Swallow capsules whole with water and do not chew or crush them. Continue treatment according to the oncologist's instructions and do not change the dose without medical advice.
Safety Information
Laronib/larotrectinib should be used under specialist oncology supervision. Important risks include central nervous system effects such as dizziness, cognitive impairment, mood changes, and sleep disturbances. Avoid driving or operating machinery if these effects occur.
Larotrectinib can also cause liver toxicity, so liver function tests are recommended before treatment and regularly during therapy. Skeletal fractures have also been reported and should be promptly evaluated if symptoms occur. Larotrectinib may cause fetal harm, so pregnancy and contraception should be discussed with the treating healthcare professional.
Common adverse reactions and laboratory abnormalities may include fatigue, nausea, vomiting, diarrhea, constipation, dizziness, cough, abdominal pain, rash, increased liver enzymes, anemia, and changes in blood-cell counts. Report severe or persistent symptoms to the treating medical team promptly.
Check the original packaging, manufacturer, batch number, expiry date, storage requirements, and authenticity before use. Laronib 100mg should only be obtained and used according to a qualified healthcare professional's prescription.
